NREU, BESMIR
 Distribuzione geografica
Continente #
NA - Nord America 2.160
EU - Europa 1.079
AS - Asia 961
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 41
AF - Africa 20
OC - Oceania 6
Totale 4.508
Nazione #
US - Stati Uniti d'America 2.114
RU - Federazione Russa 532
IT - Italia 249
SG - Singapore 230
BR - Brasile 197
CN - Cina 192
HK - Hong Kong 184
VN - Vietnam 151
IE - Irlanda 113
KR - Corea 72
SE - Svezia 67
DE - Germania 32
FR - Francia 31
IN - India 31
CA - Canada 30
JO - Giordania 22
FI - Finlandia 21
AR - Argentina 18
ID - Indonesia 15
BD - Bangladesh 11
EC - Ecuador 10
JP - Giappone 9
IQ - Iraq 8
MX - Messico 8
UA - Ucraina 8
AU - Australia 6
GB - Regno Unito 6
PK - Pakistan 6
ZA - Sudafrica 6
CO - Colombia 5
PL - Polonia 5
PY - Paraguay 5
AZ - Azerbaigian 4
ES - Italia 4
TR - Turchia 4
CI - Costa d'Avorio 3
KZ - Kazakistan 3
MA - Marocco 3
NL - Olanda 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
EG - Egitto 2
IR - Iran 2
NG - Nigeria 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.468
Città #
Santa Clara 577
Ashburn 254
Singapore 173
Fairfield 168
Hong Kong 163
Dublin 112
Woodbridge 76
Cambridge 73
Beijing 71
Seoul 71
Seattle 70
Ho Chi Minh City 61
San Jose 61
Houston 60
Milan 58
Moscow 58
Chandler 54
Wilmington 54
Lawrence 39
Hanoi 35
Altamura 34
Los Angeles 31
Council Bluffs 30
Princeton 29
Florence 25
Ann Arbor 24
Lauterbourg 23
Mumbai 23
Boston 20
Rome 19
The Dalles 19
Buffalo 17
Hefei 16
Helsinki 14
Munich 14
San Diego 14
São Paulo 12
Clifton 11
Kent 11
Falkenstein 10
Medford 10
Phoenix 10
Rio de Janeiro 10
Dallas 9
Shanghai 9
Redondo Beach 8
Boardman 7
Redwood City 7
Toronto 7
Andover 6
Guangzhou 6
Jakarta 6
Melbourne 6
Miano 6
Tokyo 6
Turin 6
Atlanta 5
Bari 5
Curitiba 5
Da Nang 5
Denver 5
Hillsboro 5
Naples 5
Paris 5
Tianjin 5
Barcelona 4
Biên Hòa 4
Bologna 4
Brooklyn 4
Chicago 4
Falls Church 4
Lahore 4
Menlo Park 4
New York 4
Quito 4
Redmond 4
Salvador 4
Thái Bình 4
Warsaw 4
Abidjan 3
Baghdad 3
Baku 3
Belo Horizonte 3
Bogotá 3
Goiânia 3
Guarulhos 3
Guayaquil 3
Hải Dương 3
Mexico City 3
Norwalk 3
Novara 3
Padua 3
Pittsburgh 3
Porto Alegre 3
Praia Grande 3
Salt Lake City 3
Abuja 2
Alvorada 2
Amsterdam 2
Aparecida do Taboado 2
Totale 2.963
Nome #
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 192
Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes? 191
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 182
Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy 180
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 177
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 173
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 173
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 169
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 169
LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias 165
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 162
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 160
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 157
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 155
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 155
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 154
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 151
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 150
Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers 143
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 142
Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized clinical trials 137
COVID-19 Vaccine Hesitancy and Early Adverse Events Reported in a Cohort of 7,881 Italian Physicians 132
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials 131
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 127
Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscany 123
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials 117
Rate and predictors of hesitancy toward sars-cov-2 vaccine among type 2 diabetic patients: Results from an italian survey 116
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 115
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials 106
Trust of Italian healthcare professionals in covid-19 (anti-sars-cov-2) vaccination 104
Totale 4.508
Categoria #
all - tutte 13.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022147 0 0 9 16 7 7 6 18 2 12 12 58
2022/2023440 66 98 35 13 13 69 67 8 45 6 17 3
2023/2024178 8 20 28 5 6 8 8 43 8 26 15 3
2024/20251.479 37 163 91 210 421 246 31 129 43 32 33 43
2025/20261.491 139 192 149 225 155 48 133 89 71 60 32 198
2026/2027142 65 46 31 0 0 0 0 0 0 0 0 0
Totale 4.508